Skip to main content
. 2015 Oct 19;112(44):E5936–E5943. doi: 10.1073/pnas.1516319112

Table S1.

Knockout of Erk1 and Erk2 in mouse ESCs with TALENs and CRISPR/Cas

Method Target gene Cell line Screened colonies Uncut, n (%) One allele cut, n (%) Two alleles cut, n (%)
CRISPR/Cas Erk1 V6.5 30 21 (70.0) 3 (10.0) 6 (20.0)
iMek1 48 23 (47.9) 7 (14.6) 18 (37.5)
Erk2−/− 24 21 (87.5) 3 (12.5) 0 (0.0)
Erk2−/−; Erk1+/− 39 39 (100.0) 0 (0.0)
Erk2 KH2 39 28 (71.8) 4 (10.3) 7 (17.9)
iMek1 48 33 (68.8) 2 (4.2) 13 (27.0)
iErk1; Erk1−/− (+Dox) 45 31 (68.9) 3 (6.7) 11 (24.4)
iErk1; Erk1−/− (−Dox) 24 20 (83.3) 4 (16.7) 0 (0.0)
TALENs Erk1 iErk1 60 50 (83.3) 8 (13.3) 2 (3.3)
iErk2; Erk2−/− (+Dox) 71 64 (90.2) 3 (4.2) 4 (5.6)
Erk2−/− 48 45 (93.8) 3 (6.2) 0 (0.0)
Erk2−/−; Erk1+/− 41 41 (100.0) 0 (0.0)
Erk2 V6.5 24 20 (83.3) 0 (0.0) 4 (16.7)

n, number of ESC clones; %, percentage of ESC clones.